News
Detailed price information for Astrazeneca Plc ADR (AZN-Q) from The Globe and Mail including charting and trades.
Havas has announced a joint venture between HAVAS Red and H/Advisors in Singapore. This will provide customers with a world ...
AstraZeneca PLC ( NASDAQ: AZN) Q2 2025 Earnings Conference Call July 29, 2025 9:00 AM ET ...
Merck is a strong and profitable pick meeting Benjamin Graham's criteria. Read more on why investors need to stay aware of ...
The UK’s National Institute for Health and Care Excellence (NICE) has issued a positive recommendation for the use of ...
USA-based Madrigal Pharmaceuticals today announced that it has entered into an exclusive global license agreement with CSPC ...
According to the latest study from BCC Research, the "Global Thyroid Gland Disorders: Diagnostics and Treatment Market" is ...
The FDA granted fast track designation for rezpegaldesleukin for treating adults and children aged 12 years and older, ...
AI-powered quantification of tumor-infiltrating lymphocytes could change how patients with melanoma are treated after surgery ...
The triple-negative breast cancer market is expected to grow due to rising incidence rates, increasing awareness, advancements in targeted therapies, ongoing clinical trials, improved diagnostics ...
AbbVie, Bristol Myers Squibb and Eli Lilly appear “relatively well-positioned,” while Novartis and Roche look more at risk, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results